1 Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases.

2 phenotypic detection of esbl, mbl (imp-1), and ampc enzymes, and their coexistence in enterobacter and klebsiella species isolated fromclinical specimens

3 pola kuman, sensitifitas antibiotik dan risiko kematian oleh kuman staphylococcus coagulase negatif pada sepsis neonatorum di rs dr moewardi surakarta

4 susceptibility of austrian clinical klebsiella and enterobacter isolates linked to patient-related data

5 Survey of US wastewater for carbapenem-resistant Enterobacteriaceae.

6 Characteristics of White-rot Fungus Phlebia brevispora TMIC33929 and Its Growth-Promoting Bacterium Enterobacter sp. TN3W-14 in the Decolorization of Dye-Contaminated Water.

7 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

8 Quinolone resistance mechanisms among third-generation cephalosporin resistant isolates of Enterobacter spp. in a Bulgarian university hospital

9 Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People’s Republic of China

10 Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

11 Molecular mechanisms related to colistin resistance in Enterobacteriaceae

12 Characterization of a carbapenem- and colistin-resistant Enterobacter cloacae carrying Tn6901 in blaNDM-1 genomic context

13 Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae

14 Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital

15 Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan

16 Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia

17 Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

18 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

19 Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

20 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

21 Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review

22 Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

23 Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia

24 Contribution of horizontal gene transfer to the emergence of VIM-4 carbapenemase producer Enterobacteriaceae in Kuwait

25 Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi

26 Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

27 The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae

28 Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

29 An Enterobacter plasmid as a new genetic background for the transposon Tn1331

30 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

31 Quinolone resistance mechanisms among third-generation cephalosporin resistant isolates of Enterobacter spp. in a Bulgarian university hospital

32 Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

33 Quinolone resistance mechanisms among third-generation cephalosporin resistant isolates of Enterobacter spp. in a Bulgarian university hospital

34 Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People’s Republic of China

35 Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

36 Molecular mechanisms related to colistin resistance in Enterobacteriaceae

37 Characterization of a carbapenem- and colistin-resistant Enterobacter cloacae carrying Tn6901 in blaNDM-1 genomic context

38 Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae

39 Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital

40 Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan

41 Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia

42 Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

43 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

44 Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

45 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

46 Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review

47 Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

48 Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia

49 Contribution of horizontal gene transfer to the emergence of VIM-4 carbapenemase producer Enterobacteriaceae in Kuwait

50 Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi

51 Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

52 The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae

53 Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

54 An Enterobacter plasmid as a new genetic background for the transposon Tn1331

55 Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.

56 Antifungal activity of volatile emitted from Enterobacter asburiae Vt-7 against Aspergillus flavus and aflatoxins in peanuts during storage

57 Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.

58 Prevalence and dissemination risk of antimicrobial-resistant Enterobacteriaceae from shared bikes in Beijing, China.

59 Characteristics of ESLB-producing enterobacteriaceae and methicillinresistant Staphylococcus aureus (MRSA) isolated from Swiss and imported raw poultry meat collected at retail level

60 Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.

61 Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.

62 Treatment of carbapenem-resistant enterobacteriaceae infections: Is there anything else?

63 Production of ethanol by Enterobacter sp. EtK3 during fruit waste biotransformation

64 Decreasing prevalence of contamination with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) in retail chicken meat in the Netherlands.

65 Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.

66 Construction of a method for predicting the number of enterobacteria in milk using artifical neural networks

67 Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

68 Occurrence of carbapenemase-producing Enterobacteriaceae in a Portuguese river: bla, bla and bla among the detected genes.

69 Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei.

70 Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

71 Characterization of a strain representing a new Enterobacter species, Enterobacter chengduensis sp. nov.

72 Genomic Investigation of a Putative Endoscope-Associated Carbapenem-Resistant Enterobacter cloacae Outbreak Reveals a Wide Diversity of Circulating Strains and Resistance Mutations

73 Comparison of three methods for identification of Enterobacteriaceae

74 Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)

75 Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae

76 study on mics of tigecycline in clinical isolates of carbapenem resistant enterobacteriaceae (cre) at a tertiary care centre in north india

77 frecuencia de enzimas asociadas a sensibilidad disminuida a betalactámicos en aislados de enterobacterias, caracas, venezuela frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, caracas, venezuela

78 isolation and determination antimicrobial susceptibility pattern of enterobacter cloacae strains isolated from consumed powdered infant formula milk in nicu ward

79 susceptibilidad antimicrobiana de enterobacterias identificadas en infección urinaria adquirida en la comunidad, en gestantes en nueve hospitales de colombia

80 yersinia enterocolitica ve bazı enterobacteriaceae türlerinin yoğurtta canlı kalma düzeyleri (İngilizce)

81 phylogenetic network analysis revealed the occurrence of horizontal gene transfer of 16s rrna in the genus enterobacter

82 extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in são luís, brazil

83 a plasmid-transposon hybrid mutagenesis system effective in a broad range of enterobacteria

84 susceptibilidad a betalactámicos y resistencia por betalactamasas de espectro extendido (blee) en enterobacteriaceae aisladas de reservorios ambientales de un hospital general en cajamarca, perú.*

85 níveis de sensibilidade de enterobactérias, em particular salmonella typhi, a rifamicina s.v.

86 molecular characteristics of first imp-4-producing enterobacter cloacae sequence type 74 and 194 in korea

87 infections bactériennes chez les écrevisses (entérobactériacées). ii - citrobacter, enterobacter.

88 probiotic lactobacillus acidophilus strain inmia 9602 er 317/402 administration reduces the numbers of candida albicans and abundance of enterobacteria in the gut microbiota of familial mediterranean fever patients

89 bacteriophages contribute to the spread of antibiotic resistance genes among foodborne pathogens of the enterobacteriaceae family – a review

90 iron, copper, zinc and manganese transport and regulation in pathogenic enterobacteria: correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence

91 mutations in the quinolone resistance-determining regions of gyra and parc in enterobacteriaceae isolates from brazil

92 serine protease autotransporters of enterobacteriaceae (spates): biogenesis and function

93 use of a selective medium with potassium tellurite to follow intestinal colonization of hospitalized patients by drug-resistant enterobacteriaceae

94 effects of breakpoint changes on carbapenem susceptibility rates ofenterobacteriaceae: results from the sentry antimicrobial surveillance program, united states, 2008 to 2012

95 biocluster: tool for identification and clustering of enterobacteriaceae based on biochemical data

96 host-toxin interactions involving espc and pet, two serine protease autotransporters of the enterobacteriaceae

97 occurrence of antimicrobial-resistant enterobacteriaceae in water from different sources in a subtropical region of argentina

98 aislamiento e identificación de enterobacter sakazakii en lactarios de bogotá, d. c isolation and identification of enterobacter sakazakii in milk feeders of bogotá, d. c

99 impact of the introduction of an automated microbiologic system on the clinical outcomes of bloodstream infections caused by enterobacteriaceae strains

100 uji aktivitas pertumbuhan enterobacter cloacae selulolitik aerob rumen-1 isolat asal limbah cairan rumen sapi peranakan ongole (growth activity assay of cellulolytic bacteria enterobacter cloacae sar 1 (cellulolytic aerob rumen 1) isolated from ongole cro

101 in vitro activity of cefepime/aai101 and comparators against cefepime non-susceptible enterobacteriaceae

Keyword Connections

Journals

Research Groups

Bibliographies